Results 151 to 160 of about 97,289 (321)
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results [PDF]
, 2017 Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment options such as CT-P13 promises to improve the availability of biological therapy,
Argüelles Arias, Federico +7 more
core
Assessment of Pain Types in Recently Diagnosed Patients With Inflammatory Arthritis
Arthritis Care &Research, Volume 78, Issue 1, Page 154-163, January 2026.Objective Up to 40% of patients with inflammatory arthritis (IA) experience persistent pain, traditionally thought to be associated with a shift from peripherally to centrally mediated pain during the disease course in some patients. We assessed sensory profiles of recently diagnosed individuals with IA, hypothesizing that pain reported at this early ...
Zoe Rutter‐Locher +8 more
wiley +1 more source
Arthritis Care &Research, Volume 78, Issue 1, Page 85-95, January 2026.Objective Axial spondyloarthritis (axSpA) is often associated with persistent pain despite effective anti‐inflammatory treatment. Digital health applications (DHAs) provide innovative approaches to address multidimensional aspects of persistent pain through psychological and behavioral strategies. The aim of this study was to assess the impact of a DHA
David Kiefer +7 more
wiley +1 more source
CASE OF A FEMALE PATIENT WITH ANKYLOSING SPONDYLITIS AND MULTIPLE ANEURYSMS [PDF]
Blagovest Stoimenov +4 more
openalex +1 more source
Beyond Inflammation: Why Understanding the Brain Matters in Inflammatory Arthritis
Arthritis Care &Research, Volume 78, Issue 1, Page 3-14, January 2026.Persistent pain remains a major challenge in inflammatory arthritis, even when joint inflammation is well controlled. Pain and associated symptoms such as fatigue cannot be explained by peripheral inflammation alone but reflect altered central pain processing. These changes may arise through “top‐down” mechanisms, reflecting pre‐existing dysfunction in
Eoin M. Kelleher +2 more
wiley +1 more source
Egyptian Rheumatology and RehabilitationBackground The wingless signaling pathway of bone development is inhibited by sclerostin, which may contribute to the etiology of ankylosing spondylitis.
Nouran Medhat Abd El Samad Sakrana +3 more
doaj +1 more source
Incidence rates of tuberculosis and inflammatory bowel disease in patients with ankylosing spondylitis treated with biologics in Korea [PDF]
Oh Chan Kwon +6 more
openalex +1 more source
Rehabilitation Referral in Rheumatology: Insights From the RISE Registry
ACR Open Rheumatology, Volume 8, Issue 1, January 2026.Objective The aim was to describe the percentage of patients with axial spondyloarthritis (axSpA), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE) in the Rheumatology Informatics System for Effectiveness (RISE) Registry who received a rehabilitation referral.
Astia Allenzara +4 more
wiley +1 more source
Clinics, 2013 OBJECTIVE: Nitric oxide is produced by endothelial nitric oxide synthase, and its production can be influenced by polymorphisms of the endothelial nitric oxide synthase gene.
Ismail Sari +9 more
doaj